IDV vehicle
36E79725D0033
4 LINE ITEMS FOR SOLIFENACIN TABLETS. AWARDED FOR A BASE YEAR OF 8/19/2025 TO 8/18/2026 PLUS 4 ONE-YEAR OPTION PERIODS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NAC PHARMACEUTICALS (36E797) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $3.9M |
| Start date | Aug 19, 2025 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Sep 9, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 9, 2026 | P00003 | $0 | THIS MODIFICATION INCORPORATES SECTION 5 OF EO 14398, CLAUSE 52.222-90, ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS (APR 2026), INTO EXISTING NATIONAL CONTRACT 36E79725D0033. |
| Jul 7, 2026 | P00002 | $0 | EXERCISED OPTION YEAR 1 FOR SOLIFENACIN TABLETS WITH GSMS. |
| May 29, 2026 | P00001 | $0 | POC CHANGE |
| May 19, 2025 | 0 | $0 | 4 LINE ITEMS FOR SOLIFENACIN TABLETS. AWARDED FOR A BASE YEAR OF 8/19/2025 TO 8/18/2026 PLUS 4 ONE-YEAR OPTION PERIODS. |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.